SI1038873T1 - Benzo(3,4)cyclobuta(1,2-c)pyrrole derivatives as inhibitors of serotonine reuptake - Google Patents

Benzo(3,4)cyclobuta(1,2-c)pyrrole derivatives as inhibitors of serotonine reuptake

Info

Publication number
SI1038873T1
SI1038873T1 SI200030008T SI200030008T SI1038873T1 SI 1038873 T1 SI1038873 T1 SI 1038873T1 SI 200030008 T SI200030008 T SI 200030008T SI 200030008 T SI200030008 T SI 200030008T SI 1038873 T1 SI1038873 T1 SI 1038873T1
Authority
SI
Slovenia
Prior art keywords
alkyl
aryl
cycloalkyl
cyclobuta
benzo
Prior art date
Application number
SI200030008T
Other languages
English (en)
Slovenian (sl)
Inventor
Jean-Louis Peglion
Bertrand Goument
Aimee Dessinges
Mark Millan
Jean-Michel Rivet
Anne Dekeyne
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of SI1038873T1 publication Critical patent/SI1038873T1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/70[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SI200030008T 1999-03-26 2000-03-24 Benzo(3,4)cyclobuta(1,2-c)pyrrole derivatives as inhibitors of serotonine reuptake SI1038873T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9903811A FR2791345B1 (fr) 1999-03-26 1999-03-26 Nouveaux derives du benzo[3,4]cyclobuta[1,2-c]pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP00400812A EP1038873B1 (de) 1999-03-26 2000-03-24 Derivate von Benzo(1,2-c)pyrrol als Inhibitoren der Serotonin Wideraufnahme

Publications (1)

Publication Number Publication Date
SI1038873T1 true SI1038873T1 (en) 2002-08-31

Family

ID=9543685

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030008T SI1038873T1 (en) 1999-03-26 2000-03-24 Benzo(3,4)cyclobuta(1,2-c)pyrrole derivatives as inhibitors of serotonine reuptake

Country Status (22)

Country Link
US (1) US6153640A (de)
EP (1) EP1038873B1 (de)
JP (1) JP3256788B2 (de)
KR (1) KR100427127B1 (de)
CN (1) CN1166638C (de)
AT (1) ATE216994T1 (de)
AU (1) AU762990B2 (de)
BR (1) BR0001420A (de)
CA (1) CA2301787C (de)
DE (1) DE60000142T2 (de)
DK (1) DK1038873T3 (de)
EA (1) EA003302B1 (de)
ES (1) ES2176156T3 (de)
FR (1) FR2791345B1 (de)
HK (1) HK1031380A1 (de)
HU (1) HUP0001246A3 (de)
NO (1) NO315513B1 (de)
NZ (1) NZ503588A (de)
PL (1) PL339203A1 (de)
PT (1) PT1038873E (de)
SI (1) SI1038873T1 (de)
ZA (1) ZA200001501B (de)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4171369A (en) * 1972-09-29 1979-10-16 Sandoz Ltd. Hydro-4-phenyl-benz[f]isoindoline compounds
DK136420B (da) * 1972-09-29 1977-10-10 Sandoz Ag Analogifremgangsmåde til fremstilling af isoindolinforbindelser.
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
US4622405A (en) * 1984-07-25 1986-11-11 Abbott Laboratories 1,2,3,3a,8,8a-hexahydro-indeno[1,2-c]pyrroles useful in the treatment of hypertension
DE3576334D1 (de) * 1984-07-25 1990-04-12 Abbott Lab 1,2,3,3a,8,8a-hexahydro-indeno-(1,2-c)pyrrde.
ES2058061T3 (es) * 1985-10-25 1994-11-01 Beecham Group Plc Derivado de piperidina, su preparacion y su uso como medicamento.
US5049564A (en) * 1989-11-17 1991-09-17 Abbott Laboratories 5-HT selective agents
GB9012469D0 (en) * 1990-06-05 1990-07-25 Glaxo Group Ltd Medicaments
US5574060A (en) * 1993-08-12 1996-11-12 The United States Of America As Represented By The Department Of Health And Human Services Selective inhibitors of biogenic amine transporters
DE4341402A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
KR100427127B1 (ko) 2004-04-17
NO315513B1 (no) 2003-09-15
NO20001542L (no) 2000-09-27
ZA200001501B (en) 2000-10-24
HUP0001246A2 (hu) 2001-01-29
AU2257900A (en) 2000-09-28
EA200000260A2 (ru) 2000-12-25
US6153640A (en) 2000-11-28
BR0001420A (pt) 2000-10-10
FR2791345A1 (fr) 2000-09-29
PT1038873E (pt) 2002-09-30
EP1038873A2 (de) 2000-09-27
JP2000290253A (ja) 2000-10-17
EP1038873A3 (de) 2000-10-04
ATE216994T1 (de) 2002-05-15
JP3256788B2 (ja) 2002-02-12
CN1166638C (zh) 2004-09-15
CA2301787C (fr) 2004-11-02
CN1274718A (zh) 2000-11-29
DE60000142T2 (de) 2002-12-12
CA2301787A1 (fr) 2000-09-26
EA003302B1 (ru) 2003-04-24
NO20001542D0 (no) 2000-03-24
DK1038873T3 (da) 2002-08-19
HU0001246D0 (en) 2000-06-28
AU762990B2 (en) 2003-07-10
EP1038873B1 (de) 2002-05-02
DE60000142D1 (de) 2002-06-06
FR2791345B1 (fr) 2001-05-04
ES2176156T3 (es) 2002-12-01
PL339203A1 (en) 2000-10-09
HUP0001246A3 (en) 2002-02-28
NZ503588A (en) 2000-12-22
HK1031380A1 (en) 2001-06-15
KR20010006863A (ko) 2001-01-26

Similar Documents

Publication Publication Date Title
ZA908884B (en) 1,2-benzisoxazole derivatives processes for preparing them and pharmaceutical compositions containing them
CO5631431A2 (es) Indoles sustituidos novedosos
ES2108425T3 (es) Analogos de atp sustituidos con n-alquilo-2.
IE38679L (en) Piperazine derivatives
NO954168L (no) Indolderivater som 5-HT1-lignende agonister for anvendelse mot migrene
AR037907A1 (es) Derivados de azaindolilalquilamina como ligandos de 5-hidroxitriptamina-6
NO20004295D0 (no) Nye pyridinforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
TW363891B (en) Aminoalkyl and acylaminoalkyl ethers, process for their preparation, and their use as bradykinin receptor
SI1038873T1 (en) Benzo(3,4)cyclobuta(1,2-c)pyrrole derivatives as inhibitors of serotonine reuptake
HK1036983A1 (en) New dihydrofuro(3,4-b)quinolin-1-one compounds, a process for their preparation and pharmaceutical compostions containing them.
CO4600635A1 (es) Procedimientos e intermedios para preparar derivados de cromanol sustituidos
EA201071014A1 (ru) Новые 7-замещенные производные 3-карбоксиоксадиазинохинолонов, способ их получения и применение в качестве антибактериальных средств
NO20065057L (no) benzoksazociner og terapeutisk anvendelse derav som monoamin reopptaks inhibitorer
DK0463944T3 (da) Hidtil ukendte acylbenzoxazolinoner, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
SE9002727D0 (sv) Novel cyclic ketone derivatives and pharmaceuticalcompositions containing same as well as a process for their preparation
NO20002940D0 (no) Nye forbindelser av 7-okso-2,3,7,14-tetrahydro-1H-benzo- [b]pyrano[3,2-h]akridinkarboksylat, en fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
NO20005797D0 (no) Nye aminopyrrolinforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO964672L (no) Nye tetracykliske 1,4-oksazinforbindelser, fremgangsmåter ved deres fremstilling og farmasöytiske sammensetninger innholdende dem
ES443519A1 (es) Procedimiento para la obtencion de derivados de benz (f) i- soindolina.
SE8701524L (sv) Nya sulfonamider och deras framstaellningsfoerfarande
SE8802162D0 (sv) Nya aminoacylater av glycerolacetal
ES2113382T3 (es) Derivados de azetidinona y procedimiento para producir derivados de azetidinona y cefalosporina.